Samir Wadke, MBA, Vice President of Business Development & Co-Founder
Mr. Wadke has led the strategic operations of the Company since its founding in 2010 and has over 20 years of cross-functional business experience. He previously consulted for early-stage lifesciences companies on corporate planning and project management. He worked in Business Development for VGX Pharmaceuticals (now Inovio Pharmaceuticals – NYSEMKT: INO), where he played a significant role in both its integration of ADViSYS and merger with Inovio, and participated in negotiations that resulted in several license agreements and other sources of funding. He previously held roles in finance, marketing, and strategy at JP Morgan, MB Financial, and UBS. He holds an M.B.A. from the University of Chicago and a B.S.E. from the University of Michigan.
Mark Eberhardt, Director of Product Development
Mr. Eberhardt joined the company in March 2020 and brings over 25 years of experience in medical device development, including over 20 years in the development of catheter-based devices. Over his career, he has produced innovations that resulted in more than a dozen patents. He has extensive experience in collecting physician feedback and utilizing it for product design. Mr. Eberhardt also brings over 15 years of experience in leading teams through all aspects of development to take products from concept through commercial sale and build the design control systems required. He has a B.S. in Mechanical Engineering from Union College, Schenectady, NY.
Nikhil Heble, PharmD, JD, Counsel, Secretary, & Co-Founder (Part-Time)
Dr. Heble is a registered patent attorney with significant experience handling intellectual property related matters, including patent procurement, infringement and validity studies, due diligence, and client counseling; particularly in the areas of diagnostics, medical devices, controlled-release delivery forms, immunomodulators, vaccines, bioadhesive films, synthetic processes, polymer-based coatings, enzymes, liquid and semi-solid formulations, nanotechnology, nutraceuticals, catalysts, and oxidizing agents. His experience also includes acquiring and licensing patents, as well as litigation.
Prior to Thubrikar Aortic Valve, Inc., Dr. Heble held the position of Senior Patent Counsel for the in-house patent department of a Fortune 500 consumer products company, where he was responsible for developing and managing the patent portfolio and business interests related to its largest business unit. Dr. Heble is currently a partner at an Am 100 firm and practices out of the Philadelphia metropolitan area.
Prior to attending law school, Dr. Heble worked as a pharmacist at Thomas Jefferson University Hospital in Philadelphia, PA. In addition to his experience at Jefferson, Dr. Heble has pharmacy experience in both government and industry settings.